<p>Cumulative incidence of vascular invasion after the initial treatment (A) and incidence stratified based on the DCP (B) and AFP-L3 (C) levels at the initial treatment.</p
<p>Multivariate adjusted hazard ratios for incidence of CKD according to the median CRP values along...
Cumulative incidence of hepatocellular carcinoma in patients who had achieved sustained virologic re...
BACKGROUND: Vascular invasion in patients with hepatocellular carcinoma (HCC) is representative of a...
<p>Cumulative incidence after HAART initiation of starting a third line regimen or failing a second ...
<p>Incidence rates of bleeding events stratified by time since start of VKA treatment.</p
<p>The incidence of pathological changes in target organs in different treatments at D15 and D42.</p
<p>The results are shown separately for (A) NDR equations, (B) UKPDS-1 equations and (C) UKPDS-2 equ...
<p>The results are shown separately for (A) NDR equations, (B) UKPDS-1 equations and (C) UKPDS-2 equ...
Cumulative incidence curves showing the probability of initiating treatment for low-risk patients (g...
Cumulative incidence rates for all-cause death/myocardial infarction in overall (A) and matched (B) ...
The NOAC and warfarin groups both showed a lower cumulative risk of efficacy outcomes compared with ...
<p>The cumulative probability of (A) major adverse cardiovascular events (MACE) or all-cause mortali...
<p>The cumulative incidence of reinfection (continuous line) and death (dashed line) after two-stage...
<p>Cumulative incidence in time to RTW in months post stroke, divided according to stroke type.</p
<p>Cumulative incidence of different types of serious hemorrhage after hospitalization for ischemic ...
<p>Multivariate adjusted hazard ratios for incidence of CKD according to the median CRP values along...
Cumulative incidence of hepatocellular carcinoma in patients who had achieved sustained virologic re...
BACKGROUND: Vascular invasion in patients with hepatocellular carcinoma (HCC) is representative of a...
<p>Cumulative incidence after HAART initiation of starting a third line regimen or failing a second ...
<p>Incidence rates of bleeding events stratified by time since start of VKA treatment.</p
<p>The incidence of pathological changes in target organs in different treatments at D15 and D42.</p
<p>The results are shown separately for (A) NDR equations, (B) UKPDS-1 equations and (C) UKPDS-2 equ...
<p>The results are shown separately for (A) NDR equations, (B) UKPDS-1 equations and (C) UKPDS-2 equ...
Cumulative incidence curves showing the probability of initiating treatment for low-risk patients (g...
Cumulative incidence rates for all-cause death/myocardial infarction in overall (A) and matched (B) ...
The NOAC and warfarin groups both showed a lower cumulative risk of efficacy outcomes compared with ...
<p>The cumulative probability of (A) major adverse cardiovascular events (MACE) or all-cause mortali...
<p>The cumulative incidence of reinfection (continuous line) and death (dashed line) after two-stage...
<p>Cumulative incidence in time to RTW in months post stroke, divided according to stroke type.</p
<p>Cumulative incidence of different types of serious hemorrhage after hospitalization for ischemic ...
<p>Multivariate adjusted hazard ratios for incidence of CKD according to the median CRP values along...
Cumulative incidence of hepatocellular carcinoma in patients who had achieved sustained virologic re...
BACKGROUND: Vascular invasion in patients with hepatocellular carcinoma (HCC) is representative of a...